Drug Pipeline

Therapeutic Development Portfolio

Leveraging AI-identified targets across multiple disease areas to advance novel drug candidates

Indication

Code

Discovery

in silico

in vitro

in vivo

Hit

Lead

Preclinical

Clinical

Autoimmune Disease

BIMM-1

-

-

Autoimmune Disease

BIMM-5

-

-

Anti-Cancer

BIMM-2

-

-

Anti-Cancer

BIMM-3

-

-

Anti-Cancer

BIMM-4

-

-

Metabolic Disease

BIMM-6

-

-

Metabolic Disease

BIMM-7

-

-

Completed Stage

In Progress

Future Stage